Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 17 · 2 feeds behind: Insider filings, 3 days, and 1 more · Every feed →

All 48Congress 0Executive branch 0Insiders 48
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

PBLS · $100K+ · 48 trades

Trades
48
Buys 48 · Sells 0
People
14
Stocks
1
Disclosed value
$125M
range midpoints · Congress & executive
Filed late
18
  1. ▲ BUYRajeev M. Shah DirectorPBLS Parabilis Medicines, Inc.$1.4Mdisclosed Jul 22 · filed the same day
  2. ▲ BUYRA Capital Nexus Fund III, L.P. DirectorPBLS Parabilis Medicines, Inc.$914Kdisclosed Jul 22 · filed 2 days after the trade
  3. ▲ BUYPeter Kolchinsky DirectorPBLS Parabilis Medicines, Inc.$1.4Mdisclosed Jul 22 · filed the same day
  4. ▲ BUYPeter Kolchinsky DirectorPBLS Parabilis Medicines, Inc.$607Kdisclosed Jul 22 · filed 1 day after the trade
  5. ▲ BUYRa Capital Management, L.P. DirectorPBLS Parabilis Medicines, Inc.$190Kdisclosed Jul 22 · filed 1 day after the trade
  6. ▲ BUYSoleus Capital Group, LLC 10% ownerPBLS Parabilis Medicines, Inc.$2.5Mdisclosed Jun 29 · filed 18 days after the trade · late
  7. ▲ BUYSoleus Capital, LLC 10% ownerPBLS Parabilis Medicines, Inc.$7.5Mdisclosed Jun 29 · filed 18 days after the trade · late
  8. ▲ BUYSoleus Capital Management, L.P. 10% ownerPBLS Parabilis Medicines, Inc.$7.5Mdisclosed Jun 29 · filed 18 days after the trade · late
  9. ▲ BUYSoleus Private Equity GP III, LLC 10% ownerPBLS Parabilis Medicines, Inc.$2.5Mdisclosed Jun 29 · filed 18 days after the trade · late
  10. ▲ BUYSoleus GP, LLC 10% ownerPBLS Parabilis Medicines, Inc.$2.5Mdisclosed Jun 29 · filed 18 days after the trade · late
  11. ▲ BUYGuy Levy 10% ownerPBLS Parabilis Medicines, Inc.$7.5Mdisclosed Jun 29 · filed 18 days after the trade · late
  12. ▲ BUYSoleus PE GP III, LLC 10% ownerPBLS Parabilis Medicines, Inc.$2.5Mdisclosed Jun 29 · filed 18 days after the trade · late
  13. ▲ BUYSoleus Capital Group, LLC 10% ownerPBLS Parabilis Medicines, Inc.$7.5Mdisclosed Jun 29 · filed 18 days after the trade · late
  14. ▲ BUYSoleus Capital Management, L.P. 10% ownerPBLS Parabilis Medicines, Inc.$2.5Mdisclosed Jun 29 · filed 18 days after the trade · late
  15. ▲ BUYSoleus Capital Master Fund, L.P. 10% ownerPBLS Parabilis Medicines, Inc.$2.5Mdisclosed Jun 29 · filed 18 days after the trade · late
  16. ▲ BUYSoleus GP, LLC 10% ownerPBLS Parabilis Medicines, Inc.$7.5Mdisclosed Jun 29 · filed 18 days after the trade · late
  17. ▲ BUYSoleus Private Equity GP III, LLC 10% ownerPBLS Parabilis Medicines, Inc.$7.5Mdisclosed Jun 29 · filed 18 days after the trade · late
  18. ▲ BUYSoleus Private Equity Fund III, L.P. 10% ownerPBLS Parabilis Medicines, Inc.$7.5Mdisclosed Jun 29 · filed 18 days after the trade · late
  19. ▲ BUYSoleus Private Equity Fund III, L.P. 10% ownerPBLS Parabilis Medicines, Inc.$2.5Mdisclosed Jun 29 · filed 18 days after the trade · late
  20. ▲ BUYSoleus Capital, LLC 10% ownerPBLS Parabilis Medicines, Inc.$2.5Mdisclosed Jun 29 · filed 18 days after the trade · late
  21. ▲ BUYSoleus PE GP III, LLC 10% ownerPBLS Parabilis Medicines, Inc.$7.5Mdisclosed Jun 29 · filed 18 days after the trade · late
  22. ▲ BUYSoleus Capital Master Fund, L.P. 10% ownerPBLS Parabilis Medicines, Inc.$7.5Mdisclosed Jun 29 · filed 18 days after the trade · late
  23. ▲ BUYGuy Levy 10% ownerPBLS Parabilis Medicines, Inc.$2.5Mdisclosed Jun 29 · filed 18 days after the trade · late